Jefferies Financial Group Inc. Mirati Therapeutics, Inc. Put Options Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	SELL	$41.99 - $62.38 $1.28 Million - $1.9 Million	-30,400 Reduced 51.01%	29,200 $1.72 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $900,720 - $1.47 Million	32,400 Added 119.12%	59,600 $2.6 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $343,476 - $510,044	-9,400 Reduced 25.68%	27,200 $1.01 Million
Q4 2022 Sep 21, 2023	BUY	$41.27 - $98.62 $387,938 - $927,028	9,400 Added 34.56%	36,600 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.51 Million - $3.61 Million	36,600 New	36,600 $1.66 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.